Wells Fargo Maintains Equal-Weight on Clorox, Lowers Price Target to $85
Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $90 to $85.
Stocks · News reference
Citigroup analyst Filippo Falorni maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $100 to $97.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $90 to $85.
Analysts highlight high-yield consumer staples Altria (6.59%), Clorox (6.22%) and General Mills (7.62%), with mixed ratings and targets.
Procter & Gamble faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as it attempts to balance pricing strategies with volume growth in a challenging consumer environment. While pricing contributed to 1% organic sales growth in fiscal 2026, volume remained flat in Q4. PG plans to shift toward more balanced growth through innovation, promotions, and disciplined pricing rather than relying solely on price increases, which risk consumer trade-downs and reduced purchase frequency.